{"url":"https://lda.gov/api/v1/filings/30e28f94-08b0-419a-9f6f-d8fa45b6174a/","filing_uuid":"30e28f94-08b0-419a-9f6f-d8fa45b6174a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/30e28f94-08b0-419a-9f6f-d8fa45b6174a/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Blair Larkins","dt_posted":"2025-04-13T13:40:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"220 S Fayette St.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401106433,"url":"https://lda.gov/api/v1/registrants/401106433/","house_registrant_id":45495,"name":"STUMPTOWN STRATEGIES","description":null,"address_1":"220 S Fayette St.","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BLAIR LARKINS","contact_telephone":"+1 503-957-6420","dt_updated":"2026-01-30T19:42:25.344705-05:00"},"client":{"id":44817,"url":"https://lda.gov/api/v1/clients/44817/","client_id":44817,"name":"PRIME THERAPEUTICS","general_description":"Healthcare","client_government_entity":null,"client_self_select":false,"state":"MN","state_display":"Minnesota","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"PBM issues - Transparency, Delinking HR 2214 Drug Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":123642,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"LARKINS","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 2214 DRUG Act Delinking, PBM Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":123642,"prefix":null,"prefix_display":null,"first_name":"BLAIR","nickname":null,"middle_name":null,"last_name":"LARKINS","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Rep. Greg Walden (2005-2006); Executive Assistant, Rep. Greg Walden (2006-2011)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}